Background Urinary tract infection (UTI) is a common health care problem. Recurrent UTI
(RUTI) in healthy non‐pregnant women is defined as three or more episodes of UTI during a …

Summary Synopsis: Co-trimoxazole1 (trimethoprim-sulfamethoxazole) is a 'broad
spectrum'antimicrobial which is active in vitro against a wide variety of micro-organisms …

The effect of daily administration of trimethoprim (TMP), trimethoprim–sulfamethoxazole
(TMP-SMX), or placebo on aerobically grown fecal gram-negative bacteria was monitored in …

We conducted a randomized, double-blind, placebo-controlled study to determine the
efficacy of postcoital antibiotic prophylaxis in healthy young women prone to recurrent …

We compared the efficacy and safety of estriol-containing vaginal pessary use with those of
oral nitrofurantoin macrocrystal (NM) therapy for preventing urinary tract infection (UTI) in …

Introduction and hypothesis The glycosaminoglycan hyaluronic acid (HA) protects the
urothelium; damage may increase bacterial adherence and infection risk. This study …

In a randomized crossover trial, 38 women with recurrent urinary tract infections were
assigned to use either continuous prophylaxis with trimethoprim-sulfamethoxazole or …

Acute uncomplicated UTI is one of the most common problems for which young women seek
medical attention, and it accounts for considerable morbidity and health care costs. Acute …

The combination trimethoprim-sulphamethoxazole (co-trimoxazole) is used clinically for the
treatment of a variety of infections due to Gram-positive and Gram-negative organisms; …

Oral trimethoprim/sulfamethoxazole (TMP/SMZ) therapy was investigated in the prophylaxis
of infections in granulocytopenia. Hospitalized granulocytopenic patients were allocated at …